Reduced serum proline levels in migraine patients [52] may indicate P5CS pathway involvement, while elevated glutamate levels [53] could reflect broader mitochondrial metabolic disturbances, potentially influencing excitatory neurotransmission and migraine pathogenesis. The gene discussed is ALDH18A1; the disease is migraine disorder.